Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Marco H.G.M. Koppelman"'
Autor:
Boris M. Hogema, Marco H.G.M. Koppelman, M.W.A. Molenaar-de Backer, Hans L. Zaaijer, Ed Slot, T J W van de Laar
Publikováno v:
Microbiology Spectrum
Microbiology Spectrum, Vol 9, Iss 2 (2021)
Microbiology spectrum, 9(2):e00253-21. American Society for Microbiology
Microbiology Spectrum, Vol 9, Iss 2 (2021)
Microbiology spectrum, 9(2):e00253-21. American Society for Microbiology
During the SARS-CoV-2 pandemic, several studies reported a lower incidence of respiratory infections other than COVID-19 compared to previous years, but bias due to changes in uptake and capacity of non-COVID care cannot be excluded. The routine scre
Publikováno v:
Transfusion, 59(9), 2931-2937. Wiley-Blackwell
Transfusion, 59(9), 2931-2937. Wiley-Blackwell Publishing Ltd
Transfusion, 59(9), 2931-2937. Wiley-Blackwell Publishing Ltd
BACKGROUND: The screening of Dutch blood donations for West Nile virus (WNV) may be imminent, as WNV emerges in nearby countries and more donors travel to WNV-affected regions. Since 2016 the related, mosquito-borne Usutu virus (USUV) causes seasonal
Publikováno v:
Transfusion. 58:641-648
Background Several countries have implemented safety strategies to reduce the risk of Zika virus (ZIKV) transmission through blood transfusion. These strategies have included nucleic acid amplification testing (NAT) of blood donations. In this study,
Autor:
Aloys C.M. Kroes, M.W.A. Molenaar-de Backer, Hans L. Zaaijer, Marco H.G.M. Koppelman, Anne Russcher, M. Lanfermeijer
Publikováno v:
Journal of Clinical Virology, 84, 19-23
Background Parvovirus B19 (B19V) DNA can be detected in blood over a long period after acute infection. Several reports associate the presence of B19V DNA with disease, irrespective of timing of the initial B19V infection. Objectives This study aims
Publikováno v:
Transfusion. 56:440-448
BACKGROUND To meet European guidelines for plasma for fractionation, plasma fractionators have implemented parvovirus B19 (B19V) and hepatitis A virus (HAV) nucleic acid test (NAT) screening on test pools. In this study we evaluate recently developed
Autor:
Maria Babizki, Lisa Danzig, Andre Lindquist, Marta Bes, Sílvia Sauleda, Marco H.G.M. Koppelman, Natalia Casamitjana, Edgar O. Ong, Maria Piron, Tim Shin, Anh Hoang, Lee Vang, Alanna Janssen, Robin E. Cory, Jeffrey M. Linnen
Publikováno v:
Transfusion. 55:972-979
Background Hepatitis E virus (HEV) is an emerging threat to the safety of blood transfusion. The aim of this study was to determine HEV immunoglobulin (Ig)G and RNA prevalence in Catalan blood donors. Study Design and Methods Nearly 10,000 samples we
Autor:
Susanna Wessberg, H. Theo M. Cuijpers, Marco H.G.M. Koppelman, Lutz Pichl, John Saldanha, Anne Valkeajärvi, Volkmar Schottstedt
Publikováno v:
Transfusion. 52:1498-1508
BACKGROUND: Three European laboratories evaluated the TaqScreen DPX test (DPX test), a multiplex nucleic acid test assay for the simultaneous detection and quantitation of parvovirus B19 (B19V) DNA and the detection of hepatitis A virus (HAV) RNA. ST
Publikováno v:
Vox Sanguinis. 100:261-266
Background and Objectives Plasma derivatives and blood components with low levels of parvovirus B19 (B19) seem not infectious, but recently infected, highly viraemic donors may transmit B19. We studied the incidence of high-level B19 viraemia (B19 DN
Autor:
L. González Ponte, Marco H.G.M. Koppelman, A. Ontañón, Hans L. Zaaijer, P.N. Lelie, H. J. Boot, P. Torres, F.J.van Hemert
Publikováno v:
Journal of medical virology, 80(8), 1344-1349. Wiley-Liss Inc.
Occult hepatitis B virus (HBV) infection is characterized by the presence of HBV DNA while the HBV surface antigen (HBsAg) remains undetectable. The HBV genomes in five asymptomatic blood donors with occult HBV infection and low viremia (
Publikováno v:
Journal of general virology, 88(Part 8), 2137-2143. Society for General Microbiology
The genome of hepatitis B virus (HBV) provides a striking example of gene overlapping. In particular, the surface protein gene S is overlapped completely by the polymerase gene P. Evolutionary constraints in overlapping genes have been demonstrated f